FdaApplication
NDA 020356
Identifiers
- fda_app_no: NDA020356
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1995-02-02 |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SULAR | NISOLDIPINE | 8.5MG | TABLET, EXTENDED RELEASE;ORAL |
| SULAR | NISOLDIPINE | 17MG | TABLET, EXTENDED RELEASE;ORAL |
| SULAR | NISOLDIPINE | 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
| SULAR | NISOLDIPINE | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
| SULAR | NISOLDIPINE | 34MG | TABLET, EXTENDED RELEASE;ORAL |
| SULAR | NISOLDIPINE | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
| SULAR | NISOLDIPINE | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
| SULAR | NISOLDIPINE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
8 products